CH535262A - Verfahren zur Herstellung von Steroiden - Google Patents

Verfahren zur Herstellung von Steroiden

Info

Publication number
CH535262A
CH535262A CH266370A CH266370A CH535262A CH 535262 A CH535262 A CH 535262A CH 266370 A CH266370 A CH 266370A CH 266370 A CH266370 A CH 266370A CH 535262 A CH535262 A CH 535262A
Authority
CH
Switzerland
Prior art keywords
steroids
making
making steroids
Prior art date
Application number
CH266370A
Other languages
English (en)
Inventor
Hartmann Werner
Kurt Dr Barnikol-Oettler
Teichmueller Gerhard
Original Assignee
Jenapharm Veb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Veb filed Critical Jenapharm Veb
Publication of CH535262A publication Critical patent/CH535262A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH266370A 1969-03-05 1970-02-24 Verfahren zur Herstellung von Steroiden CH535262A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD13838269 1969-03-05

Publications (1)

Publication Number Publication Date
CH535262A true CH535262A (de) 1973-03-31

Family

ID=5481000

Family Applications (1)

Application Number Title Priority Date Filing Date
CH266370A CH535262A (de) 1969-03-05 1970-02-24 Verfahren zur Herstellung von Steroiden

Country Status (5)

Country Link
AT (1) AT301768B (de)
CH (1) CH535262A (de)
DE (1) DE2004516A1 (de)
RO (1) RO56117A (de)
SE (1) SE355359B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
CA2430100A1 (en) * 2000-11-27 2002-05-30 Entremed, Inc. Antiangiogenic agents
CA2646065C (en) 2006-03-20 2014-01-14 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol

Also Published As

Publication number Publication date
AT301768B (de) 1972-08-15
SE355359B (de) 1973-04-16
DE2004516A1 (en) 1970-09-10
RO56117A (de) 1974-06-01

Similar Documents

Publication Publication Date Title
CH457422A (de) Verfahren zur Herstellung von Steroiden
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
CH535262A (de) Verfahren zur Herstellung von Steroiden
CH499564A (de) Verfahren zur Herstellung von Poly-B-Alanin
AT293608B (de) Verfahren zur Herstellung von Elixieren
CH489537A (de) Verfahren zur Herstellung von Urikase
AT294733B (de) Verfahren zur Herstellung von Uricase
AT303980B (de) Verfahren zur herstellung von neuen steroiden
CH511307A (de) Verfahren zur Herstellung von Flechtwerk
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
AT316766B (de) Verfahren zur Herstellung von Steroiden
CH513844A (de) Verfahren zur Herstellung von Steroiden
CH507542A (de) Verfahren zur Herstellung von Zifferblättern
CH553737A (de) Verfahren zur herstellung von hexahydrophenanthrenverbindungen.
AT322120B (de) Verfahren zur herstellung von neuen steroiden
AT297936B (de) Verfahren zur Herstellung von Suppositorien
AT308292B (de) Verfahren zur Herstellung von neuen Steroiden
AT301770B (de) Verfahren zur Herstellung von 17α-Propadienylsteroiden
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH491889A (de) Verfahren zur Herstellung von Steroiden
CH470374A (de) Verfahren zur Herstellung von Steroiden
AT319486B (de) Verfahren zur Herstellung von Steroiden

Legal Events

Date Code Title Description
PL Patent ceased